Spring 2023
By Colleen Sullivan
Emerald Foundation, Inc., awarded $300,000 to support research harnessing natural killer (NK) cells for use in immunotherapies. NK cells play a major role in the elimination of both tumors and infected cells, and this research will provide valuable insight that will inform better treatment strategies.